Volume 35, Issue 10 pp. 1197-1201
Article
Full Access

Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts

Akira Ito PhD

Corresponding Author

Akira Ito PhD

Department of Biochemistry, Tokyo College of Pharmacy, Horinouchi, Hachioji, Tokyo

Department of Biochemistry, Tokyo College of Pharmacy, Horinouchi, Hachioji, Tokyo 192–03, JapanSearch for more papers by this author
Yoshifumi Itoh MS

Yoshifumi Itoh MS

Department of Biochemistry, Tokyo College of Pharmacy, Horinouchi, Hachioji, Tokyo

Search for more papers by this author
Yo Mori PhD

Yo Mori PhD

Department of Biochemistry, Tokyo College of Pharmacy, Horinouchi, Hachioji, Tokyo

Search for more papers by this author
Yasuyuki Sasaguri MD, PhD

Yasuyuki Sasaguri MD, PhD

Second Department of Pathology, Kurume University School of Medicine, Kurume, Fukuoka, Japan

Search for more papers by this author
Minoru Morimatsu MD, PhD

Minoru Morimatsu MD, PhD

Second Department of Pathology, Kurume University School of Medicine, Kurume, Fukuoka, Japan

Search for more papers by this author
First published: October 1992
Citations: 74

Abstract

Objective. High levels of interleukin-6 (IL-6) have been found in the synovial fluid of patients with rheumatoid arthritis (RA). We undertook the present study to investigate the role of IL-6 in this disease.

Methods. We examined the effects of IL-6, in comparison with IL-1, on the biosynthesis of extracellular matrix macromolecules and of matrix-degrading proteinases in rheumatoid synovial fibroblasts.

Results. In rheumatoid synovial fibroblasts, IL-6 by itself enhanced the production of plasminogen activator, its inhibitor, and tissue inhibitor of metalloproteinases, whereas it did not modulate the biosynthesis of precursor of matrix metalloproteinase 1 (proMMP-1) (tissue collagenase), proMMP-3 (stromelysin), or connective tissue components. However, IL-1–induced production of proMMP-1 and proMMP-3 was preferentially augmented by IL-6.

Conclusion. These results suggest that in RA, IL-6 may participate along with IL-1 in fine tuning of the catabolism of connective tissue components, by modulating the balance between connective tissue–degrading enzymes and their inhibitors.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me